Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MVA85A and Delayed BCG in HIV-Exposed Infants
NCT01650389Phase 2Completed
- Start
- Oct 2012
- Primary completion
- May 2015
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MVA85A in Tuberculosis (TB). Started Oct 2012; status: completed.
02
Drugs
MVA85A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01650389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650389.